In a previous interview, Lee hinted that a period of market volatility is expected, as 2024 heads for a soft landing.
In the latest market close, Pfizer (PFE) reached $29.08, with a -0.27% movement compared to the previous day. The stock's performance was behind the S&P 500's daily gain of 0.77%. Meanwhile, the Dow ...
Goldman Sachs senior biotechnology analyst in global investment research Chris Shibutani joins Market Domination Hosts Julie ...
We recently compiled a list of the David Einhorn’s Stock Portfolio: Top 10 Stocks to Buy. In this article, we are going to ...
With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to ...
The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...
The major U.S. stock market indexes are officially in overheated territory thanks to enthusiasm for artificial intelligence ...